Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 613 pembrolizumab 583 Magnetic Resonance Spectroscopy 543 Carboplatin 430 Cyclophosphamide 380 Cisplatin 377 Biopsy 366 Paclitaxel 314 Nivolumab 312 Gemcitabine 308 Radiotherapy 268 Bevacizumab 230 Dexamethasone 217 fludarabine 205 Docetaxel 190 durvalumab 188 venetoclax 187 Oxaliplatin 187 Rituximab 174 Fluorouracil 174 atezolizumab 169 Pemetrexed 166 Capecitabine 162 Radiosurgery 160 Doxorubicin 160 Radiation 156 Ipilimumab 144 Lenalidomide 140 Leucovorin 138 Etoposide 134

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fenretinide × 90 days × Clear all

NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡